Bain Capital Life Sciences Inv's Net Worth
Bain Capital Life Sciences Inv's net worth is estimated to be at least $100,650,016.02 as of 12/23/2024. CoreStreet's estimation of Bain Capital Life Sciences Inv's net worth is based on their sale of stock and current holding of stock.
Bain Capital Life Sciences Inv is Major Shareholder at Annexon Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 300,000 units of ANNX stock on 05/25/2023. Their biggest sale was on 08/10/2021 when they sold 1,000,000 units of SpringWorks Therapeutics Inc stock for $70,250,000.00. They typically trade 1 times per year.
Total value of insider buys:
- $13,709,714.96
Total value of insider sells:
- $86,940,301.06
Most recent insider trade:
- May 25, 2023
Bain Capital Life Sciences Inv's Insider Trading History
| Annexon Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 25, 2023 | Major Shareholder | 300,000 | $2.13 | Buy | $639,000.00 |
| Xilio Development Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 10, 2021 | Major Shareholder | 25,000 | $9.65 | Buy | $241,250.00 |
Dec. 8, 2021 | Major Shareholder | 13,458 | $9.62 | Buy | $129,465.96 |
| SpringWorks Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 10, 2021 | Major Shareholder | 1,000,000 | $70.25 | Sell | $70,250,000.00 |
Sept. 17, 2019 | Major Shareholder | 150,000 | $18.00 | Buy | $2,700,000.00 |
| Aptinyx Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 26, 2020 | Major Shareholder | 3,333,333 | $3.00 | Buy | $9,999,999.00 |
| Marinus Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 19, 2017 | Major Shareholder | 1,272,547 | $7.88 | Sell | $10,027,670.36 |
Dec. 15, 2017 | Major Shareholder | 822,547 | $8.10 | Sell | $6,662,630.70 |